1. Home
  2. VTEX vs BME Comparison

VTEX vs BME Comparison

Compare VTEX & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VTEX

VTEX

VTEX

HOLD

Current Price

$3.81

Market Cap

561.5M

Sector

Technology

ML Signal

HOLD

Logo Blackrock Health Sciences Trust

BME

Blackrock Health Sciences Trust

HOLD

Current Price

$39.93

Market Cap

547.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTEX
BME
Founded
1999
N/A
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Trusts Except Educational Religious and Charitable
Sector
Technology
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
561.5M
547.5M
IPO Year
2019
2005

Fundamental Metrics

Financial Performance
Metric
VTEX
BME
Price
$3.81
$39.93
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$5.97
N/A
AVG Volume (30 Days)
1.2M
36.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$12.64
N/A
Revenue Next Year
$10.57
N/A
P/E Ratio
$43.33
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.84
$34.18
52 Week High
$6.82
$42.74

Technical Indicators

Market Signals
Indicator
VTEX
BME
Relative Strength Index (RSI) 60.25 22.68
Support Level $3.68 $35.48
Resistance Level $3.84 $42.55
Average True Range (ATR) 0.19 0.59
MACD 0.07 -0.26
Stochastic Oscillator 67.64 0.00

Price Performance

Historical Comparison
VTEX
BME

About VTEX VTEX

Vtex provides a software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce plan, including building online stores, integrating and managing orders across channels, and creating marketplaces to sell products from third-party vendors. It generates maximum revenues from Brazil followed by Latin America and the rest of the world.

About BME Blackrock Health Sciences Trust

Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.

Share on Social Networks: